Keros Therapeutics CEO to participate in healthcare conferences, focusing on product candidates like cibotercept

From GlobeNewswire: 2025-02-28 17:00:00

Keros Therapeutics, Inc. announced that CEO Jasbir S. Seehra, Ph.D. will be participating in healthcare conferences like TD Cowen 45th Annual Healthcare Conference and Leerink Partners Global Healthcare Conference. Archived replays will be available on the Keros website for up to 90 days after each event. Keros focuses on developing therapeutics for disorders related to dysfunctional signaling of the TGF-ß family of proteins. They are working on product candidates like cibotercept (KER-012) for pulmonary arterial hypertension and cardiovascular disorders, KER-065 for neuromuscular diseases, and elritercept (KER-050) for low blood cell counts in patients with certain syndromes. Contact Justin Frantz at [email protected] or 617-221-6042 for investor inquiries.



Read more at GlobeNewswire: Keros Therapeutics Announces Participation at Upcoming